Jul 21, 2021 09:53AM
Jul 20, 2021 09:57AM
Jul 7, 2021 06:01AM
Jun 28, 2021 06:02AM
Jun 24, 2021 09:10AM
Jun 11, 2021 08:10AM
Jun 9, 2021 04:47PM I-Mab (IMAB) PT Raised to $90 at Cantor Fitzgerald on Pipeline Enhancements
Jun 4, 2021 06:12AM
Jun 2, 2021 06:06AM
Jun 1, 2021 01:30AM
Jun 1, 2021 01:30AM
May 5, 2021 01:30AM
May 5, 2021 01:30AM
May 4, 2021 01:30AM Nicox : Lancement de VYZULTA® (solution ophtalmique de latanoprostène bunod), 0,024% à Taiwan par son partenaire Bausch + Lomb - Approbation de VYZULTA® au Qatar
May 4, 2021 01:30AM
Apr 30, 2021 01:30AM
Apr 30, 2021 01:30AM
Apr 27, 2021 01:30AM
Apr 27, 2021 01:30AM
Apr 23, 2021 01:30AM
Apr 22, 2021 01:30AM Nicox : Eligibilité à une extension de la durée de brevets américains couvrant le latanoprostène bunod commercialisé sous le nom de VYZULTA®
Apr 22, 2021 01:30AM
Apr 19, 2021 01:30AM
Apr 19, 2021 01:30AM
Apr 16, 2021 08:12AM
Apr 13, 2021 11:45AM
Apr 6, 2021 11:02AM
Apr 6, 2021 10:25AM Soliton (SOLY) PT Raised to $25 at Cantor Fitzgerald
Mar 23, 2021 02:30AM
Mar 23, 2021 02:30AM
Mar 10, 2021 09:10AM
Mar 5, 2021 11:45AM
Mar 5, 2021 11:45AM
Mar 5, 2021 10:55AM
Mar 4, 2021 01:30AM Nicox’s NCX 470 Receives Approval by Chinese Authorities for Local Start of Denali Phase 3 Trial
Mar 4, 2021 01:30AM
Mar 2, 2021 01:30AM
Mar 2, 2021 01:30AM
Mar 1, 2021 01:30AM
Mar 1, 2021 01:30AM
Feb 23, 2021 01:30AM
Feb 23, 2021 01:30AM Nicox Announces the Publication in Leading Scientific Journal of Pre-Clinical Efficacy Results on a New Class of Non-PGA NO-donating IOP-Lowering Compounds
Feb 22, 2021 12:33PM
Feb 22, 2021 06:50AM
Feb 22, 2021 12:07AM
Feb 19, 2021 07:39AM
Feb 15, 2021 01:30AM
Feb 15, 2021 01:30AM
Feb 11, 2021 07:30AM Humanigen to Present and Participate at Multiple Upcoming Investor and Industry Conferences
Feb 4, 2021 06:47AM

618 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All